Compare VERI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERI | ANIK |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.0M | 198.9M |
| IPO Year | 2017 | 1996 |
| Metric | VERI | ANIK |
|---|---|---|
| Price | $1.57 | $14.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 2.8M | 54.5K |
| Earning Date | 04-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ N/A | N/A |
| Revenue | $92,637,000.00 | ★ $112,819,000.00 |
| Revenue This Year | $52.20 | $5.98 |
| Revenue Next Year | $3.06 | $7.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.29 | $7.90 |
| 52 Week High | $9.42 | $16.24 |
| Indicator | VERI | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 32.78 | 52.01 |
| Support Level | N/A | $13.91 |
| Resistance Level | $2.35 | $15.01 |
| Average True Range (ATR) | 0.14 | 0.53 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 5.19 | 53.27 |
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.